Comparison between Low- and Standard-Dose ACTH Tests in Premature Infants at Risk for Chronic Lung Disease

• Published in: Hormone research Vol. 52; no. 6; pp. 274 - 278
• Main Authors: Nykänen, Päivi, Heinonen, Kirsti, Voutilainen, Raimo
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland S. Karger AG 01.01.1999
• Subjects: Adrenocorticotropic Hormone - administration & dosage; Chronic Disease; Dexamethasone - therapeutic use; Gestational Age; Glucocorticoids - therapeutic use; Humans; Hydrocortisone - secretion; Infant, Newborn; Infant, Premature; Kinetics; Lung Diseases - diagnosis; Lung Diseases - drug therapy; Original Paper; Risk Factors; Dexamethasone treatment; Low-dose ACTH test; Very-low-birth-weight infant; Chronic lung disease
• ISSN: 1663-2818; 0301-0163; 1663-2826
• DOI: 10.1159/000023494

In order to find a sensitive method to evaluate adrenocortical function in premature infants, we compared low- (0.5 μg/1.73 m 2 ) and standard-dose (250 μg/1.73 m 2 ) adrenocorticotropin tests (LD- and SD-ACTH) in 12 very-low-birth-weight infants before and 2 days after the end of dexamethasone therapy (duration 9–14 days) for chronic lung disease. Basal serum cortisol levels were inappropriately low in several infants already before dexamethasone therapy (median 190, range 60–357 nmol/l). The 95% confidence intervals of mean serum cortisol levels at 20 min were equal in LD- and SD-ACTH, while at 60 min, the low-dose gave a clearly lower response than the standard-dose test. The LD-ACTH can be used in premature infants as in older children and adults, but the criteria for adrenocortical insufficiency need to be defined.